In the genotype analysis, men who are homozygote for the rare allele for VDR SNP rs2107301 had a 2.5-fold higher risk of prostate cancer compared with those who are homozygote for the common allele (95% CI: 1.52–4.00; p = 0.002). This evidence concerns the gene VDR and prostate carcinoma.